These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 24673083)

  • 61. Knowledge, attitude and practices of pharmacovigilance and adverse drug reaction reporting among pharmacists working in secondary and tertiary governmental hospitals in Kuwait.
    Alsaleh FM; Alzaid SW; Abahussain EA; Bayoud T; Lemay J
    Saudi Pharm J; 2017 Sep; 25(6):830-837. PubMed ID: 28951666
    [No Abstract]   [Full Text] [Related]  

  • 62. Overview of pharmacovigilance practices at the largest academic healthcare system in the State of Qatar.
    Al Hail M; Elkassem W; Hamad A; Abdulrouf P; Thomas B; Stewart D
    Int J Clin Pharm; 2018 Aug; 40(4):769-774. PubMed ID: 29616393
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Healthcare professionals' awareness and knowledge of adverse drug reactions and pharmacovigilance.
    Almandil NB
    Saudi Med J; 2016 Dec; 37(12):1359-1364. PubMed ID: 27874152
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Predictive Factors of Spontaneous Reporting of Adverse Drug Reactions among Community Pharmacists.
    Yu YM; Lee E; Koo BS; Jeong KH; Choi KH; Kang LK; Lee MS; Choi KH; Oh JM; Shin WG
    PLoS One; 2016; 11(5):e0155517. PubMed ID: 27192159
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Nurses' attitudes and spontaneous adverse drug reaction reporting: a case-control study in Portugal.
    Mendes Marques JI; Polónia JM; Figueiras AG; Costa Santos CM; Herdeiro MT
    J Nurs Manag; 2016 Apr; 24(3):409-16. PubMed ID: 26481698
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Adverse drug reaction reporting by community pharmacists-The barriers and facilitators.
    Hughes ML; Weiss M
    Pharmacoepidemiol Drug Saf; 2019 Dec; 28(12):1552-1559. PubMed ID: 31131966
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Non-response in a pharmacy and patient-based intensive monitoring system: a quantitative study on non-response bias and reasons for non-response.
    Härmark LV; Huls HJ; de Gier JJ; van Grootheest AC
    Int J Pharm Pract; 2014 Apr; 22(2):159-62. PubMed ID: 23683068
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Founding an adverse drug reaction (ADR) network: a method for improving doctors spontaneous ADR reporting in a general hospital.
    Goldstein LH; Berlin M; Saliba W; Elias M; Berkovitch M
    J Clin Pharmacol; 2013 Nov; 53(11):1220-5. PubMed ID: 23852627
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Assessment of an active pharmacovigilance system carried out by a pharmacist].
    Sánchez I; Amador C; Plaza JC; Correa G; Amador R
    Rev Med Chil; 2014 Aug; 142(8):998-1005. PubMed ID: 25424672
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Pharmacovigilance in the Middle East: a survey of 13 arabic-speaking countries.
    Wilbur K
    Drug Saf; 2013 Jan; 36(1):25-30. PubMed ID: 23315293
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Knowledge, perception and practice of pharmacovigilance among community pharmacists in South India.
    Prakasam A; Nidamanuri A; Kumar S
    Pharm Pract (Granada); 2012 Oct; 10(4):222-6. PubMed ID: 24155840
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Pharmacists' attitudes toward adverse drug reaction reporting in Hong Kong.
    Lee KK; Chan TY; Raymond K; Critchley JA
    Ann Pharmacother; 1994 Dec; 28(12):1400-3. PubMed ID: 7696734
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Influence of pharmacists' attitudes on adverse drug reaction reporting : a case-control study in Portugal.
    Herdeiro MT; Figueiras A; Polónia J; Gestal-Otero JJ
    Drug Saf; 2006; 29(4):331-40. PubMed ID: 16569082
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Qualitative Study of General Public Views towards Adverse Drug Reactions in Lithuania.
    Valinciute-Jankauskiene A; Loreta K
    Healthcare (Basel); 2021 Mar; 9(3):. PubMed ID: 33803215
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Characteristics and quality of adverse drug reaction reports by pharmacists in Norway.
    Gedde-Dahl A; Harg P; Stenberg-Nilsen H; Buajordet M; Granas AG; Horn AM
    Pharmacoepidemiol Drug Saf; 2007 Sep; 16(9):999-1005. PubMed ID: 17457794
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Assessing knowledge, attitude, and practices of health-care providers toward pharmacovigilance and adverse drug reaction reporting at a comprehensive cancer center in Jordan.
    Al Rabayah AA; Hanoun EM; Al Rumman RH
    Perspect Clin Res; 2019; 10(3):115-120. PubMed ID: 31404206
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Nurses' reporting of suspect adverse drug reactions: a mixed-methods study.
    De Angelis A; Giusti A; Colaceci S; Vellone E; Alvaro R
    Ann Ist Super Sanita; 2015; 51(4):277-83. PubMed ID: 26783213
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A Qualitative Evaluation of Adverse Drug Reaction Reporting System in Pakistan: Findings from the Nurses' Perspective.
    Hussain R; Hassali MA; Ur Rehman A; Muneswarao J; Atif M; Babar ZU
    Int J Environ Res Public Health; 2020 Apr; 17(9):. PubMed ID: 32349339
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Views of British community pharmacists on direct patient reporting of adverse drug reactions (ADRs).
    Krska J
    Pharmacoepidemiol Drug Saf; 2013 Oct; 22(10):1130-3. PubMed ID: 22729956
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Pharmacists' role in reporting adverse drug reactions in an international perspective.
    van Grootheest K; Olsson S; Couper M; de Jong-van den Berg L
    Pharmacoepidemiol Drug Saf; 2004 Jul; 13(7):457-64. PubMed ID: 15269929
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.